Ultragenyx Pharmaceutical Inc. (RARE)

Last Three Months

26-Aug-24 -- 25-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Strong Sell

Insider Trading Sentiment: Strong Buy

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

26

0

0

+1

0

+2

0

+3

Two Year Chart

26-Nov-22 -- 25-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
05-Sep-24 11:53 AM View:	03-Sep-24 Sale ($1.12M)	Kakkis Emil D President & CEO Director		Ultragenyx Pharmaceutical Inc. - RARE	(1%) 2.81M to 2.79M	0	0	--	--	Show Txns Hide Txns

18-Sep-24 1:03 PM View:	16-Sep-24 Grant 0	Huizenga Theodore Alan SVP, Chief Accounting Officer		Ultragenyx Pharmaceutical Inc. - RARE	1% 41.64K to 42.25K	0	0	--	--	Show Txns Hide Txns

11-Oct-24 4:48 PM View:	10-Oct-24 Sale ($393.85K)	Horn Howard Chief Financial Officer		Ultragenyx Pharmaceutical Inc. - RARE	(7%) 99.77K to 92.3K	0	0	--	--	Show Txns Hide Txns